| 000 | 00871 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250515002651.0 | ||
| 264 | 0 | _c20060317 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a0968-0896 | ||
| 024 | 7 |
_a10.1016/j.bmc.2005.09.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEspinoza-Fonseca, L Michel | |
| 245 | 0 | 0 |
_aThe benefits of the multi-target approach in drug design and discovery. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _cFeb 2006 |
||
| 300 |
_a896-7 p. _bdigital |
||
| 500 | _aPublication Type: Editorial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aLigands |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 14 _gno. 4 _gp. 896-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2005.09.011 _zAvailable from publisher's website |
| 999 |
_c15833214 _d15833214 |
||